# Intrapleural Urokinase for Retained Hemothorax

> **NCT01134237** · PHASE3 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 32 (estimated)

## Conditions studied

- Retained Hemothorax

## Interventions

- **DRUG:** urokinase
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01134237
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-05
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2010-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01134237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01134237, "Intrapleural Urokinase for Retained Hemothorax". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01134237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*